Back to Search Start Over

Benralizumab Effectiveness in Severe Eosinophilic Asthma with and without Chronic Rhinosinusitis with Nasal Polyps: A Real-World Multicenter Study

Authors :
Nolasco, Santi
Crimi, Claudia
Pelaia, Corrado
Benfante, Alida
Caiaffa, Maria Filomena
Calabrese, Cecilia
Carpagnano, Giovanna Elisiana
Ciotta, Domenico
D'Amato, Maria
Macchia, Luigi
Pelaia, Girolamo
Pellegrino, Simona
Scichilone, Nicola
Scioscia, Giulia
Spadaro, Giuseppe
Campisi, Raffaele
Valenti, Giuseppe
Vatrella, Alessandro
Crimi, Nunzio
Source :
The Journal of Allergy and Clinical Immunology: In Practice; 20210101, Issue: Preprints
Publication Year :
2021

Abstract

Chronic rhinosinusitis with nasal polyps (CRSwNP) affects around 60% of patients with severe eosinophilic asthma (SEA). Benralizumab was recently approved for SEA add-on treatment.

Details

Language :
English
ISSN :
22132198
Issue :
Preprints
Database :
Supplemental Index
Journal :
The Journal of Allergy and Clinical Immunology: In Practice
Publication Type :
Periodical
Accession number :
ejs57463488
Full Text :
https://doi.org/10.1016/j.jaip.2021.08.004